Morphologic cell profiling of SARS-CoV-2 infected cells enables drug repurposing screening

8 Feb 2022
Morphologic cell profiling of SARS-CoV-2 infected cells enables drug repurposing screening

In this video, the profiling of SARS-CoV-2 infected cells in order to repurpose drugs is discussed.

Other videos from Yokogawa Corp. of America

Links